110 related articles for article (PubMed ID: 26327351)
1. Pulmonary Fibrosis Treated with Inhaled Interferon-gamma (IFN-γ).
Fusiak T; Smaldone GC; Condos R
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):406-10. PubMed ID: 26327351
[TBL] [Abstract][Full Text] [Related]
2. Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis.
Diaz KT; Skaria S; Harris K; Solomita M; Lau S; Bauer K; Smaldone GC; Condos R
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):79-87. PubMed ID: 22360317
[TBL] [Abstract][Full Text] [Related]
3. Inhaled Interferon and Diffusion Capacity in Idiopathic Pulmonary Fibrosis (IPF).
Skaria SD; Yang J; Condos R; Smaldone GC
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):37-42. PubMed ID: 26237354
[TBL] [Abstract][Full Text] [Related]
4. Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosis.
Luppi F; Losi M; D'Amico R; Fabbri LM; Richeldi L
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):64-8. PubMed ID: 19960790
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of gamma interferon via inhalation delivery.
Smaldone GC
Adv Drug Deliv Rev; 2018 Aug; 133():87-92. PubMed ID: 29886069
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.
Markart P; Nass R; Ruppert C; Hundack L; Wygrecka M; Korfei M; Boedeker RH; Staehler G; Kroll H; Scheuch G; Seeger W; Guenther A
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):161-72. PubMed ID: 20109123
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis.
Nathan SD; Barnett SD; Moran B; Helman DL; Nicholson K; Ahmad S; Shorr AF
Respiration; 2004; 71(1):77-82. PubMed ID: 14872115
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.
Antoniou KM; Nicholson AG; Dimadi M; Malagari K; Latsi P; Rapti A; Tzanakis N; Trigidou R; Polychronopoulos V; Bouros D
Eur Respir J; 2006 Sep; 28(3):496-504. PubMed ID: 16611657
[TBL] [Abstract][Full Text] [Related]
9. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.
King TE; Albera C; Bradford WZ; Costabel U; Hormel P; Lancaster L; Noble PW; Sahn SA; Szwarcberg J; Thomeer M; Valeyre D; du Bois RM;
Lancet; 2009 Jul; 374(9685):222-8. PubMed ID: 19570573
[TBL] [Abstract][Full Text] [Related]
10. [Different cytokine profiles in usual interstitial pneumonia and nonspecific interstitial pneumonia].
Gu L; Xu WB; Liu HR; Guo ZJ; Xu XX; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jun; 26(6):350-3. PubMed ID: 12899768
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosis: A prospective, single-arm study.
Okuda R; Matsushima H; Oba T; Kawabe R; Matsubayashi M; Amano M; Nishizawa T; Honda K
Respir Investig; 2016 May; 54(3):156-61. PubMed ID: 27108010
[TBL] [Abstract][Full Text] [Related]
12. New perspectives in the treatment of idiopathic pulmonary fibrosis.
Rogliani P; Mura M; Assunta Porretta M; Saltini C
Ther Adv Respir Dis; 2008 Apr; 2(2):75-93. PubMed ID: 19124361
[TBL] [Abstract][Full Text] [Related]
13. Cytokine modulation in patients with idiopathic pulmonary fibrosis undergoing treatment with steroids, immunosuppressants, and IFN-γ 1b.
Marinari S; De Iuliis V; Dadorante V; Colella S; Marino A; Nunziata A; Flati V; Caruso M; Pennelli A; De Benedetto F; Matera S; Capodifoglio S; Martinotti S; Caputi S; Toniato E
J Biol Regul Homeost Agents; 2017; 31(1):59-69. PubMed ID: 28337871
[TBL] [Abstract][Full Text] [Related]
14. Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients.
Antoniou KM; Tzanakis N; Tzortzaki EG; Malagari K; Koutsopoulos AV; Alexandrakis M; Wells AU; Siafakas NM
Pulm Pharmacol Ther; 2008 Dec; 21(6):840-4. PubMed ID: 18644457
[TBL] [Abstract][Full Text] [Related]
15. Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency.
Hallstrand TS; Ochs HD; Zhu Q; Liles WC
Eur Respir J; 2004 Sep; 24(3):367-70. PubMed ID: 15358692
[TBL] [Abstract][Full Text] [Related]
16. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.
Moua T; Zamora Martinez AC; Baqir M; Vassallo R; Limper AH; Ryu JH
Respir Res; 2014 Dec; 15(1):154. PubMed ID: 25472884
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of inhaled N-acetylcysteine in patients with idiopathic pulmonary fibrosis.
Bando M; Hosono T; Mato N; Nakaya T; Yamasawa H; Ohno S; Sugiyama Y
Intern Med; 2010; 49(21):2289-96. PubMed ID: 21048362
[TBL] [Abstract][Full Text] [Related]
18. Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis.
Honoré I; Nunes H; Groussard O; Kambouchner M; Chambellan A; Aubier M; Valeyre D; Crestani B
Am J Respir Crit Care Med; 2003 Apr; 167(7):953-7. PubMed ID: 12663336
[TBL] [Abstract][Full Text] [Related]
19. Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes.
Halme M; Maasilta P; Repo H; Ristola M; Taskinen E; Mattson K; Cantell K
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):93-101. PubMed ID: 7995773
[TBL] [Abstract][Full Text] [Related]
20. The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man.
Syrjä P; Heikkilä HP; Lilja-Maula L; Krafft E; Clercx C; Day MJ; Rönty M; Myllärniemi M; Rajamäki MM
J Comp Pathol; 2013; 149(2-3):303-13. PubMed ID: 23664319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
